Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (91-100 of 188) with videos related to

Pageof 19
Sort By:
Blood Advances|December 12, 2022
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemiaShai Shimony, Yiwen Liu, Yannis K Valtis, et al.
Pediatric Blood & Cancer|September 17, 2015
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic LeukemiaLynda M Vrooman, Ivan I Kirov, ZoAnn E Dreyer, et al.
Pediatric Blood & Cancer|October 2, 2012
The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011Stephen P Hunger, Andre Baruchel, Andrea Biondi, et al.
Cancer Discovery|July 5, 2014
Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199Triona Ni Chonghaile, Justine E Roderick, Cian Glenfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatmentVirginia Kimball Dalton, Montse Rue, Lewis B Silverman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicityDeborah P Waber, Lewis B Silverman, Lori Catania, et al.
Blood|September 28, 2006
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaAlbert Moghrabi, Donna E Levy, Barbara Asselin, et al.
Pharmacogenomics|November 6, 2019
Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patientsVincent Gagné, Anne Aubry-Morin, Maria Plesa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.
Cancer Cell|March 7, 2003
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classificationScott A Armstrong, Andrew L Kung, Meghann E Mabon, et al.
Pageof 19

Showing results (91-100 of 188) with videos related to

Sort By:
Pageof 19
Blood Advances|December 12, 2022
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemiaShai Shimony, Yiwen Liu, Yannis K Valtis, et al.
Pediatric Blood & Cancer|September 17, 2015
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic LeukemiaLynda M Vrooman, Ivan I Kirov, ZoAnn E Dreyer, et al.
Pediatric Blood & Cancer|October 2, 2012
The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011Stephen P Hunger, Andre Baruchel, Andrea Biondi, et al.
Cancer Discovery|July 5, 2014
Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199Triona Ni Chonghaile, Justine E Roderick, Cian Glenfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatmentVirginia Kimball Dalton, Montse Rue, Lewis B Silverman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicityDeborah P Waber, Lewis B Silverman, Lori Catania, et al.
Blood|September 28, 2006
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaAlbert Moghrabi, Donna E Levy, Barbara Asselin, et al.
Pharmacogenomics|November 6, 2019
Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patientsVincent Gagné, Anne Aubry-Morin, Maria Plesa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.
Cancer Cell|March 7, 2003
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classificationScott A Armstrong, Andrew L Kung, Meghann E Mabon, et al.
Pageof 19